making news with our
portfolio companies

Published FDA Pivotal Studies Find DermaSensor has 96% Sensitivity and Cuts Physician’s Missed Skin Cancers by Half
Published in the Journal of Primary Care and Community Health, the joint FDA pivotal studies demonstrated the performance and benefits of the hand-held, non-invasive, optical spectroscopy device in point-of-care skin lesion evaluation.
